FLUCELVAX sol inj 15 µg 0.5 ml PFS 1 pce

7680701440010 CH-70144 J07BB02 08.08.

No images available

Details

Product number
7014401
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H1N1) (Virus Stamm A/Wisconsin/67/2022 (H1N1)-like: derived from A/Georgia/12/2022 CVR-167) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Massachusetts/18/2022 (H3N2)-like: derived from A/Sydney/1304/2022) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant from B/Singapore/WUH4618/2021 (Victoria lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.74 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum.

Articles (1)

Flucelvax, Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/08/2026
Professional SmPC
Français
18/08/2026
Professional SmPC
Italien
18/08/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.74 MG Substance HBESI
kalium
0.1 MG Substance HBESI
polysorbatum 80
- Substance RESI
cetrimidum
- Substance RESI
propiolactonum
- Substance RESI

Authorization holder

Vifor (International) Inc.

9014 St. Gallen

Authorization information

Swissmedic authorization number
70144
Drug name
Flucelvax, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
29/04/2026
Authorization expiration date
28/04/2031
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza von Erwachsenen, Jugendlichen und Kindern ab 2 Jahren

Packaging details

Description (FR)
FLUCELVAX sol inj 15 µg 0.5 ml PFS 1 pce
Description (DE)
FLUCELVAX Inj Lös 15 µg 0.5 ml PFS 1 Stk
Market launch
16/06/2028
Narcotic (BTM)
No

Other packaging sizes

FLUCELVAX sol inj 15 µg 0.5 ml PFS 10 pce
10 FESP
GTIN: 7680701440027
View
FLUCELVAX sol inj 15 µg 0.5 ml PFS aig 1 pce
1 FESP
GTIN: 7680701440034
View
FLUCELVAX sol inj 15 µg 0.5 ml PFS aig 10 pce
10 FESP
GTIN: 7680701440041
View
Buy us a coffee Explore the data